Guest guest Posted January 9, 2004 Report Share Posted January 9, 2004 I understand that general frustration with the slow pace of acceptance for resurfacing in the US. But I think it's unfair to blame the average OS in the US for this. Two things will change the hip replacement landscape. 1. FDA approval 2. Marketing efforts by orthopeadic companies once FDA approval occurs. No reputable journal, organization, or individual OS is going to promote or encourage a procedure until it becomes " standard of care " . Even OSs who do resurfacing are careful to avoid pushing patients in that direction. It is presented as one option and carefully characterized as " investigational " . Resurfacing is a tremendous boon to hip patients who are young and active. Once resurfacing is FDA approved, it will join the other arrows in most OS's quivers and become commonplace. Until then it will remain a relatively obscure and questionable procedure in the US. To charactorize US surgeons as reactionary is unfair. And it's also not productive to try and rate one country's surgeons above another's. This forum is for discussion and support, not competition or promotion. Mike Trautman C2K, Kennedy, Sep 03 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.